Exelixis Inc.

(EXEL) Trade

By |

Profile

Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company.

Contact Information

Website: www.exelixis.com
Email: shubbard@exelixis.com
Main Phone: +1 650 837-7000
Address: 210 East Grand Avenue
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Michael M. Morrissey
Employees: 372
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
$ 21.86 $ -0.06 (-0.27%)
Last Price 21.86 Change $ -0.06 Change % -0.27 Tick N/A
Bid 21.87 Bid Size 400.00 Ask 22.28 Ask Size 400.00
Open 21.97 High 22.21 Low 21.70 Prev Close 21.92
Last Trade Volume 2.8 mi 52 Wk Hi 32.50 52 Wk Low 18.50
Market Cap 6.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 296,866,380.00 EPS (TTM) 0.81 PE Ratio 27.00 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 35 97
Number of Buys 21 48
Number of Sells 14 49
Net Activity 67225 16693
Last 10 Buys Shares
Lance Willsey 1,000
Lance Willsey 1,000
Lance Willsey 1,000
Lance Willsey 1,000
Vincent T. Marchesi 1,000
Vincent T. Marchesi 1,000
Lance Willsey 1,000
Lance Willsey 1,000
Lance Willsey 1,000
Vincent T. Marchesi 1,000
Last 10 Sell Shares
Michael M. Morrissey 1,000
Lance Willsey 1,000
Patrick J. Haley 1,000
Vincent T. Marchesi 1,000
Charles Cohen 1,000
Patrick J. Haley 1,000
Stelios Papadopoulos 1,000
Patrick J. Haley 1,000
Jeffrey J. Hessekiel 1,000
Gisela M. Schwab 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 40 40 40 40
Low Target Price Estimate 29 29 29 29
Mean Target Price Estimate 33.83 33.83 33.83 33.83
Standard Deviation 5.12 5.12 5.12 5.12
Date of Most Recent Estimate 06/01/18 05/29/18 05/17/18 06/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 2 2 1 2
Hold 1 1 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.63 1.8